The UK NSC policy on Alzheimer's Disease screening in adults
|Last review completed
|Next review due in
|| Systematic population screening programme not recommended
Screening should not be offered.
|| Last external review
What is screening?
Screening is a process of identifying apparently healthy people who may be at increased risk of a disease or condition. They can then be offered information, further tests and appropriate treatment to reduce their risk and/or any complications arising from the disease or condition.
It is important to ensure that the benefits and downsides of screening have been properly thought through. The UK National Screening Committee (UK NSC) is responsible for reviewing screening policies every 3 years and making recommendations to ministers in the 4 UK countries about whether to not a screening programme for a certain condition should be set up.
» Find out more about screening, the role of the UK NSC or the policy review process
More about Alzheimer's Disease
Alzheimer's disease is the most common form of dementia, which describes the loss of mental abilities, such as memory and reasoning. Alzheimer's disease is a progressive condition, meaning it will continue to get worse as it develops. Unfortunately, there is no cure for the condition, although there is treatment that can slow down the development.
» Read more about alzheimer's disease on NHS Choices
• Alzheimer's Research Trust
• Alzheimer's Society
• Association of British Neurologists
• The British Psychological Society
• Royal College of General Practitioners
• Royal College of Physicians
• Royal College of Psychiatrists
The stakeholder groups will be involved when the policy is next reviewed.
If you think your organisation should be added, please
More about the policy review process, including the role of stakeholders,
can be found in the guide to Engaging with the UK NSC's policy review process.
More optionsGo to top